| P2093 | author name string | Luis Marín | |
| | Fernando Ramos | |
| | Marcos González | |
| | Pilar Giraldo | |
| | Teresa Bernal | |
| | Jesús F San Miguel | |
| | Ramón García-Sanz | |
| | Carlos Santamaría | |
| | María Belén Vidriales | |
| | María Dolores Caballero | |
| | Alfonso García de Coca | |
| | Ana Balanzategui | |
| | Joaquín Díaz-Mediavilla | |
| | José Antonio Queizán | |
| | María Carmen Chillón | |
| | María Eugenia Sarasquete | |
| | María Jesús Peñarrubia | |
| | Miguel Alcoceba | |
| P2860 | cites work | Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. | Q27824774 |
| | The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia | Q27851416 |
| | Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups | Q28143548 |
| | Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. | Q31012437 |
| | Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial | Q34503779 |
| | A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group. | Q34505708 |
| | Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis | Q34523534 |
| | Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease | Q34524219 |
| | Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group | Q34542746 |
| | Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results | Q34584443 |
| | The roles of FLT3 in hematopoiesis and leukemia | Q34784925 |
| | The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease | Q35087052 |
| | Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. | Q35561038 |
| | Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia | Q35849643 |
| | Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias | Q38347392 |
| | Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm. | Q44189526 |
| | Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol | Q44194162 |
| | Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129. | Q44240279 |
| | High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARα expression | Q44443187 |
| | Internal tandem duplication and Asp835 mutations of the FMS-like tyrosine kinase 3 (FLT3) gene in acute promyelocytic leukemia | Q44584679 |
| | The size of duplication does not add to the prognostic significance of FLT3 internal tandem duplication in acute myeloid leukemia patients | Q47320656 |
| | FLT3-activating mutations are associated with poor prognostic features in AML at diagnosis but they are not an independent prognostic factor. | Q47418242 |
| | BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications | Q48684574 |
| | Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia | Q49279553 |
| | The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes. | Q51815688 |
| | Analysis of survival by tumor response. | Q52874285 |
| | Quantification of AML1-ETO fusion transcript as a prognostic indicator in acute myeloid leukemia. | Q53610570 |
| | The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia. | Q54514626 |
| | Impact of FLT3 mutations and promyelocytic leukaemia-breakpoint on clinical characteristics and prognosis in acute promyelocytic leukaemia. | Q54652934 |
| | New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFBMYH11+ acute myeloid leukemia based on quantification of fusion transcripts. | Q54765670 |
| | Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group | Q58416097 |
| | Impact of FLT3 mutations and secondary cytogenetic changes on the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with a single agent arsenic trioxide regimen | Q62015508 |
| | Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group | Q74082941 |
| | The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements | Q77755387 |
| | Using quantification of the PML-RARalpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia | Q79879693 |
| | Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia | Q81074303 |
| P433 | issue | 5 | |
| P921 | main subject | acute promyelocytic leukemia | Q612108 |
| | leukemia | Q29496 |
| P304 | page(s) | 745-751 | |
| P577 | publication date | 2010-02-04 | |
| P1433 | published in | Haematologica | Q5638209 |
| P1476 | title | Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients | |
| P478 | volume | 95 | |